Quotient Sciences Acquires Arcinova

Read the press release here

C&I Article: The Whole Package

In an article for C&I magazine on the 23rd November 2016, Ian Shott discusses future plans for the Alnwick site, transforming it into a profitable organisation, with potential sales of £20m by 2020. 

Shott realises the uniqueness and excellence of the Alnwick site, claiming "I've been all over the world... and never seen anything like this where preclinical to small-scale manufacturing is all together". 

Click here to download PDF




Discover how Arcinova can help

We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.

GET IN TOUCH